These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9554283)

  • 1. Kinetics, localization and characteristics of B- and T-cell responses to iscoms containing human influenza virus glycoproteins.
    Johansson M; Lövgren-Bengtsson K; Sjölander A; Morein B
    Dev Biol Stand; 1998; 92():289-94. PubMed ID: 9554283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Lövgren Bengtsson K; Johansson M; Morein B
    Scand J Immunol; 1996 Feb; 43(2):164-72. PubMed ID: 8633196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
    Sjölander A; Bengtsson KL; Morein B
    Vaccine; 1997 Jun; 15(9):1030-8. PubMed ID: 9261953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity.
    van Zijverden M; van der Pijl A; Bol M; van Pinxteren FA; de Haar C; Penninks AH; van Loveren H; Pieters R
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):131-9. PubMed ID: 11032768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
    de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
    Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza.
    Vajdy M; Baudner B; Del Giudice G; O'Hagan D
    Clin Immunol; 2007 May; 123(2):166-75. PubMed ID: 17349825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IgM antibodies versus B cells in influenza virus-specific immunity.
    Kopf M; Brombacher F; Bachmann MF
    Eur J Immunol; 2002 Aug; 32(8):2229-36. PubMed ID: 12209635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of antigen-presenting B cells from peripheral to mucosal lymphoid tissues may induce intestinal antigen-specific IgA following parenteral immunization.
    Coffin SE; Clark SL; Bos NA; Brubaker JO; Offit PA
    J Immunol; 1999 Sep; 163(6):3064-70. PubMed ID: 10477570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
    J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice.
    Sambhara S; Switzer I; Kurichh A; Miranda R; Urbanczyk L; James O; Underdown B; Klein M; Burt D
    Cell Immunol; 1998 Jul; 187(1):13-8. PubMed ID: 9681998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
    Pertmer TM; Robinson HL
    Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by iscoms, immune stimulating complexes.
    Morein B; Bengtsson KL
    Methods; 1999 Sep; 19(1):94-102. PubMed ID: 10525444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
    Hu KF; Regner M; Siegrist CA; Lambert P; Chen M; Bengtsson KL; Morein B
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):269-76. PubMed ID: 15681158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
    Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice.
    Hauge S; Madhun AS; Cox RJ; Brokstad KA; Haaheim LR
    Scand J Immunol; 2007 Jan; 65(1):14-21. PubMed ID: 17212762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iscoms with different quillaja saponin components differ in their immunomodulating activities.
    Johansson M; Lövgren-Bengtsson K
    Vaccine; 1999 Jul; 17(22):2894-900. PubMed ID: 10438061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
    Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
    J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
    Sha Z; Kang SM; Compans RW
    Virology; 2005 Jan; 331(2):387-95. PubMed ID: 15629781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.